Literature DB >> 2029119

Metastatic endophthalmitis: a reappraisal.

S P Garg1, D Talwar, L K Verma.   

Abstract

In view of the lack of studies of metastatic endophthalmitis and the controversies surrounding its management, we did a retrospective study of ten cases of metastatic endophthalmitis admitted to our center in 1987. A disproportionately high incidence of pediatric patients was found. The etiologic diagnosis was possible in eight of the ten cases. Bacterial infection was responsible in five of the eight cases where positive cultures were grown. Pseudomonas aeruginosa was the most common bacterial pathogen isolated. Most of the cases responded poorly to medical management. Seven of the ten patients finally underwent vitrectomy. Four of these seven cases had a postoperative visual acuity equal to or greater than 6/60 after vitrectomy. We believe that pars plana vitrectomy has a definite role in the management of metastatic endophthalmitis.

Entities:  

Mesh:

Year:  1991        PMID: 2029119

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  3 in total

1.  Bilateral endogenous endophthalmitis caused by vancomycin-resistant Staphylococcus epidermidis in a neonate.

Authors:  Nidhi Relhan; Thomas Albini; Avinash Pathengay; Harry W Flynn
Journal:  J Ophthalmic Inflamm Infect       Date:  2015-04-10

2.  Clinical presentations, microbiology and management outcomes of culture-proven endogenous endophthalmitis in India.

Authors:  Vivek Pravin Dave; Avinash Pathengay; Bhavik Panchal; Animesh Jindal; Agniv Datta; Savitri Sharma; Rajeev Reddy Pappuru; Joveeta Joseph; Subhadra Jalali; Taraprasad Das
Journal:  Indian J Ophthalmol       Date:  2020-05       Impact factor: 1.848

Review 3.  Endogenous endophthalmitis in children and adolescents: Case series and literature review.

Authors:  Aditya Maitray; Ekta Rishi; Pukhraj Rishi; Lingam Gopal; Pramod Bhende; Rupak Ray; Kuzhanthai Lily Therese
Journal:  Indian J Ophthalmol       Date:  2019-06       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.